The first CytRx trade was made in Q4 2017.
Since then Ken Griffin bought shares two more times and sold shares on two occasions. The investor sold all their shares in Q1 2019 and doesn't own any shares in CytRx anymore.
Avg closing price
Price range
Sold -34.6 Thousand shares
Q1 2019
Avg closing price
-
Price range
-
-
-
Increased shares by 14.9% (+4.48 Thousand shares)
Q4 2018